Menu
Recruiting NCT05285007

Limited Ankle Dorsiflexion and Effect on Single Limb Squats in Individuals With Patellofemoral Pain

No phase Interventional Patellofemoral Pain

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Mobilization with Movement, No mobilization with movement and education.
Who it may be relevant to
Registry conditions: Patellofemoral Pain. Basic parameters: 18 years — 59 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Limited Ankle Dorsiflexion and Effect on Single Limb Squats in Individuals With Patellofemoral Pain: Interventions and Outcomes in a Randomized Clinical Trial

Overview

The purpose of this graduate student research study is to investigate the relationship between limited ankle dorsiflexion and the potential effects on a single limb squat task in the Patellofemoral/Knee Pain population.

Detailed description

1. Participants will undergo Covid screening prior to filling out consent form and PHI. Randomization will occur to create an experimental group and a minimal intervention group. 2. Participants will complete two self-reported questionnaires on how their diagnosis affects functional activities. 3. Dorsiflexion range of motion in a weight bearing position will be taken. 4. Hip abductor strength on tested limb will be measure on isokinetic device. 5. The Lateral Step Down test will be conducted for 6 trials on each participant, 3 with a heel wedge and 3 without, movement recorded, and graded using two motion capture devices. 6. The experimental group will receive two interventions to increase dorsiflexion range of motion. The minimal intervention group will read and infographic and complete 5 minutes of treadmill walking. 7. Each participant will then have their dorsiflexion measured again prior to completing another 3 trials of the Lateral Step Down test.

Interventions

  • Other Mobilization with Movement
    Participants will be lunging on a box with posterior ankle glide of 10 seconds times 5 sets. They will have 30 seconds rest between trials. Participant will have their ankle taped and then walk on a treadmill at a self-selected pace for 5 minutes.
  • Other No mobilization with movement and education
    Participants ankle will not be taped and they will walk on the treadmill for 5 minutes and receive education.

Primary outcome measures

  • Weight bearing lunge test [Time frame: change between baseline and post intervention on Day 1]
Secondary outcome measures (1)
  • Patellofemoral Disability Index [Time frame: change between baseline and post intervention on Day 1]

Eligibility criteria

Inclusion criteria

  • History of active Patellofemoral Pain for at least 6 months
  • No clinic based therapeutic interventions for a 6-month period prior to testing
  • Females aged 18-59 years' old
  • Limited ankle dorsiflexion as noted by <45degs using the weight bearing lunge test

Exclusion criteria

  • History of musculoskeletal surgery or fractures on the tested leg or lumbar spine that could affect their biomechanics during the study
  • History of soft tissue or skeletal abnormalities in the tested limb
  • Current knee effusion
  • Resting pain greater than 5/10

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Other

Study locations

United States · 1 center
  • Loma Linda University — Loma Linda

Identifiers

NCT: NCT05285007 · 5220026

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗